Literatura científica selecionada sobre o tema "Complications oculaires"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Complications oculaires".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "Complications oculaires"
Regnier, Alain, Mathilde Goetz e Jean-Yves Douet. "Complications de la chirurgie oculaire chez le cheval". Le Nouveau Praticien Vétérinaire équine 16 (outubro de 2022): 22–36. http://dx.doi.org/10.1051/npvequi/2023006.
Texto completo da fonteGoldstein, Andrei, Julia Hilly e Julie Laboure-Wolf. "Complications oculaires en anesthésie". Le Praticien en Anesthésie Réanimation 10, n.º 6 (dezembro de 2006): 439–44. http://dx.doi.org/10.1016/s1279-7960(06)75643-1.
Texto completo da fonteBarry, A., AI Baldé, AB Kamissoko, M. Ndong Obiang, M. Sanda, K. Condé e M. Touré. "Manifestations oculaires au cours des spondyloarthrites en Guinée". Rhumatologie Africaine Francophone 3, n.º 2 (16 de outubro de 2022): 6–12. http://dx.doi.org/10.62455/raf.v3i2.34.
Texto completo da fonteZamalhèto, Z., L. Legheda, H. Dossou-yovo, M. Gounongbé e I. Sounouvou. "L’œil des patients souffrant de connectivites à Cotonou (Bénin)". Rhumatologie Africaine Francophone 1, n.º 2 (31 de agosto de 2021): 17–22. http://dx.doi.org/10.62455/raf.v1i2.6.
Texto completo da fonteMartenet, A. C. "Complications oculaires du SIDA - Problèmes diagnostiques". Klinische Monatsblätter für Augenheilkunde 200, n.º 05 (maio de 1992): 555–58. http://dx.doi.org/10.1055/s-2008-1045826.
Texto completo da fonteNghe, Marie-Claire. "Complications oculaires en chirurgie non ophtalmologique". Le Praticien en Anesthésie Réanimation 22, n.º 4 (setembro de 2018): 195–202. http://dx.doi.org/10.1016/j.pratan.2018.06.008.
Texto completo da fonteHéron, E., I. Rossignol, A. Chibani, F. Mihoubi-Mantout, M. Baudrimont, M. Sterkers e S. Feldman-Billard. "Complications oculaires de la maladie de Horton". La Revue de Médecine Interne 28 (junho de 2007): 57. http://dx.doi.org/10.1016/j.revmed.2007.03.077.
Texto completo da fonteMAZARI, Fettouma. "The place of eye exam in the follow-up of the arterial hypertension". Batna Journal of Medical Sciences (BJMS) 6, n.º 1 (1 de julho de 2019): 77–81. http://dx.doi.org/10.48087/bjmscr.2019.6124.
Texto completo da fonteMathis, T., V. Fortoul, L. Kodjikian e P. Denis. "Complications oculaires de l’implant esthétique coloré NewColorIris®". Journal Français d'Ophtalmologie 38, n.º 6 (junho de 2015): e107-e109. http://dx.doi.org/10.1016/j.jfo.2014.12.004.
Texto completo da fonteEz-zahraoui, M. R., M. Y. El Bakkouri, I. Hajji e A. Moutaouakil. "Complications oculaires secondaires au traitement d’un ptérygion par apipuncture". Journal Français d'Ophtalmologie 40, n.º 5 (maio de 2017): 447–49. http://dx.doi.org/10.1016/j.jfo.2016.11.020.
Texto completo da fonteTeses / dissertações sobre o assunto "Complications oculaires"
Mercié, Martial. "Syndromes paranéoplasiques oculaires". Bordeaux 2, 1997. http://www.theses.fr/1997BOR23016.
Texto completo da fonteBAKRI, MOTASSEM. "Les complications oculaires des angiomes immatures de la paupiere : a propos de 11 observations". Lyon 1, 1989. http://www.theses.fr/1989LYO1M293.
Texto completo da fontePokitonoff, Mathilde Catherine Sophie. "Contribution à l'étude des complications oculaires de l'influenza Thèse pour le doctorat en médecine présentée et soutenue le jeudi 24 juillet 1890 /". Paris : BIUM, 2003. http://www.bium.univ-paris5.fr/histmed/medica/cote?TPAR1890x362.
Texto completo da fonteCassagne, Myriam. "Etude physiopathologique des complications oculaires observées chez des patients atteints de dermatite atopique traitée par Dupilumab". Electronic Thesis or Diss., Toulouse 3, 2023. http://www.theses.fr/2023TOU30288.
Texto completo da fonteDupilumab has proven its efficacy in the treatment of moderate to severe atopic dermatitis (AD). However, the occurrence of ocular adverse events (OAEs) has been reported. The objectives of this work were to describe the incidence and nature of OAEs induced by dupilumab in AD patients, to evaluate potential predisposing factors, and to understand their molecular bases. We conducted a first single-center, prospective, real-life study in adult AD patients treated with dupilumab, who were systematically examined by an ophthalmologist before and during treatment. We included 46 patients with a median initial SCORing of AD (SCORAD) of 46.0 (interquartile range: 34.5-55.5). 34.8% of patients experienced OAEs, often mild to moderate, but leading to interruption of dupilumab for two patients. The majority of patients developed or worsened dry eye. Six patients (13%) developed conjunctivitis de novo. Dupilumab-induced OAEs were associated with dry eye with superficial punctuate keratitis (Odds ratio (OR) = 6.3 95% confidence interval (CI): [1.3-31.6]), eyelid eczema (OR= 8.7; 95% CI: [1.8-40.6]), a history of food allergy (OR = 3.8; 95% CI: [1.002-14.070]) and/or serum IgE levels > 1.000 kU/L (OR = 10.6; 95% CI: [1.2-91.3]). We then participated to a national multicenter study which included 181 patients. Thirty-four patients (18.7%) presented blepharoconjunctivitis induced by dupilumab: either de novo (n=32; 17.6%) or by worsening of a pre-existing condition (n=2; 1.1%). Most events (27/34; 79.4%) were moderate. Multivariate analysis showed that AD with head and neck involvement (OR = 7.254; 95% CI [1.938-30.07]; p = 0.004), erythroderma (OR = 5.635; 95% CI [1.635] -21.50]; p = 0.007) and the presence of dry eye syndrome before treatment (OR = 3.51; 95% CI [3.158-13.90]; p = 0.031) were independent factors associated with dupilumab-induced blepharoconjunctivitis. The SCORAD or the response to treatment (% improvement in SCORAD at W16), a history of allergic conjunctivitis, asthma or rhinitis were also not significantly associated with the occurrence of OAE. Finally, we conducted a bicentric study, comparing the transcriptome (analyzed by DNA microarrays and RT-qPCR) and the expression of the chemokine CCL20 (by ELISA) of conjunctival cells, collected by conjunctival impression, on AD patients before (M0) and 4 months after dupilumab beginning (M4). Thirty-six patients were included and divided in two groups, according their ophthalmological status at M4: one group of 12 who developed OAE (OAE+) and another group of 24 who did not (OAE-). In multiple analysis of the full transcriptome, we found 52 differentially expressed genes (DEG) between OAE+/M0 and OAE-/M0, 113 DEG between OAE+/M4 and OAE-/M4, two DEG between OAE+/M0 and OAE+/M4, and none DEG between OAE-/M0 and OAE-/M4. Ingenuity Pathway Analysis enrichment with a special interest in diseases, mainly indicated a psoriasis signature. Among the 15 DEG selected for RT-qPCR validation, only 7 were significant: CCL20, IL-19, NOX1, NOS2, SLC26A4 and S100A12 were up-regulated, whereas MUC-7 was downregulated in OAE+/M4 vs OAE-/M4 patients. CCL20 protein quantification by ELISA confirmed an over-expression between M0 and M4 for the two groups. In conclusion, most cases of dupilumab-induced blepharoconjunctivitis are de novo. Pre-existing factors (dry eye syndrome, AD with eyelid, head and neck) are associated with an increased risk of OAE. Dupilumab seems to switch AD immunological profile of OAE patients from Th2 to Th17, particularly involved in psoriasis
Lellouche, Eric. "L'immunité locale dans deux parasitoses oculaires, toxoplasmose et onchocércose". Paris 5, 1993. http://www.theses.fr/1993PA05P084.
Texto completo da fonteGaboriaud, Corinne. "Manifestations ophtalmologiques des vascularites : à propos de deux cas". Bordeaux 2, 1992. http://www.theses.fr/1992BOR2M076.
Texto completo da fonteJAIME, SONIA. "Complications immediates et secondaires des plaies penetrantes du segment anterieur (limbe inclus, corps etrangers intra-oculaires inclus, sequelles eloignees exclues)". Lyon 1, 1988. http://www.theses.fr/1988LYO1M213.
Texto completo da fonteBelso, Laurence. "Syndrome de Terson : étude rétrospective à propos de quatre cas". Montpellier 1, 1997. http://www.theses.fr/1997MON11163.
Texto completo da fonteGodenèche, Benoît. "Glaucome évolutif à pression intra-oculaire normalisée. Etude à partir de l'enregistrement sur le nycthémère de la tension oculaire couplé à la tension artérielle". Bordeaux 2, 1997. http://www.theses.fr/1997BOR23078.
Texto completo da fontePLOEGAERTS, PHILIPPE. "Segment posterieur et radiations ionisantes : a propos de 36 cas de tumeur intra-oculaire traites par radiotherapie". Lille 2, 1991. http://www.theses.fr/1991LIL2M016.
Texto completo da fonteLivros sobre o assunto "Complications oculaires"
1934-, Fraunfelder Frederick T., Roy Frederick Hampton e Meyer S. Martha, eds. Current ocular therapy 3. Philadelphia: Saunders, 1990.
Encontre o texto completo da fonteOphthalmology, American Academy of. Lens and cataract, 2007-2008. 2a ed. [San Francisco]: American Academy of Ophthalmology, 2007.
Encontre o texto completo da fonteTakao, Kumazawa, Kruger Lawrence e Mizumura Kazue, eds. The polymodal receptor: A gateway to pathological pain. Amsterdam: Elsevier, 1996.
Encontre o texto completo da fonteFrauenfelder e Roy. Current Ocular Therapy, Book 3. W.B. Saunders Company, 1989.
Encontre o texto completo da fonte(Editor), T. Kumazawa, L. Kruger (Editor) e K. Mizumura (Editor), eds. The Polymodal Receptor - A Gateway to Pathological Pain (Progress in Brain Research). Elsevier Science, 1996.
Encontre o texto completo da fonteTrabalhos de conferências sobre o assunto "Complications oculaires"
Landric, C., C. Alande e M. Ndiaye. "Apport de la greffe gingivale épithélio conjonctive dans la reconstruction palpébrale". In 66ème Congrès de la SFCO. Les Ulis, France: EDP Sciences, 2020. http://dx.doi.org/10.1051/sfco/20206602014.
Texto completo da fonte